Back to Market返回行情

TDOC Teladoc Health, Inc.

USHealthcare
$9.28+0.76%ClosedMarket Cap: $1.68B

As of 2026-07-10 16:00

Why TDOC matters now

Teladoc Health, Inc. (TDOC) is a US stock in Healthcare. The latest InvestLog snapshot shows $9.28 with +0.76% on the session and $1.68B in market capitalization; recent performance reads 1-month +22.09% and YTD +15.29%.

The latest financial table shown here is Q1 2026, with revenue of $613.8M, net income of $-63.8M, and EPS of $-0.36. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 17.2%.

The latest indexable market news headline is "Teladoc (TDOC) Rises Higher Than Market: Key Facts" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Hold with a median target of $6.00; recent insider activity includes DIVITA CHARLES III filing S-Sale. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.08

P/S

0.58

EV/EBITDA

30.43

DCF Value

$16.86

FCF Yield

17.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

65.6%

Operating Margin

-7.6%

Net Margin

-6.8%

ROE

-12.4%

ROA

-6.1%

ROIC

-7.3%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$613.8M$-63.8M$-0.36
Q4 2025$642.3M$-25.1M$-0.14
FY 2025$2.53B$-200.3M$-1.14
Q3 2025$626.4M$-49.5M$-0.28

Analyst Ratings

Consensus

Hold

Target (Consensus)

$7.40

Target (Median)

$6.00

Target Range

$6.00 - $11.00

Strong Buy: 1Buy: 6Hold: 19Sell: 0Strong Sell: 0
CitigroupNeutral
2026-05-05
Evercore ISI GroupIn Line
2026-04-08
BarclaysEqual Weight
2026-03-26
JP MorganNeutral
2026-03-13
Deutsche BankBuy
2026-03-10

Trading Activity

Insider Trades

DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER
Sell2026-06-12
DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER
Sell2026-06-12
DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER
Sell2026-06-12
DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER
Sell2026-06-12
DIVITA CHARLES IIIdirector, officer: CHIEF EXECUTIVE OFFICER
Sell2026-06-12

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

Beta

2.14

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.